B3 vitamin component fights carcinogen action in human cells, says research

October 24, 2017, FAPESP

Benzo[a]pyrene is a potent carcinogen and mutagen present in cigarette smoke, automotive exhaust, burnt wood fumes, barbecued and smoked meat etc.

Understanding the mechanisms whereby benzo[a]pyrene, which belongs to the class of (PAHs), may induce malignant transformation of human is the aim of a research project led by Ana Paula de Melo Loureiro, a professor at the University of São Paulo's School of Pharmaceutical Sciences (FCF-USP) in Brazil.

According to Loureiro, the idea is to identify the cellular pathways or sequences of biological reactions involved in the development of cancer and hence find possible targets for prevention or treatment of the disease. "Tests have shown that supplementing with nicotinamide riboside, one of the components of vitamin B3, protects cells and prevents ," she said. "We now want to find out exactly how this happens and whether the compound in question can be used in chemoprevention."

In experiments performed with regular lung cell cultures—more precisely, those of bronchial epithelial cells—were exposed to 0.5 and 1 micromolar (μM) benzo[a]pyrene for seven days. Recent data in the scientific literature suggests that the appearance of tumors is closely associated with genetic alterations and also with epigenetic alterations that may activate the expression of protumoral genes or silence protective genes, for example.

What most drew the scientists' attention, however, was a significant drop in the levels of metabolites involved in the production of energy for cells shortly after the first hour of exposure to benzo[a]pyrene. Throughout the exposure period, the cells readapted metabolically, and by the end of the period, the levels of metabolites had risen in exposed cells compared with the control group.

"It was for this reason that we had the idea of supplementing the cultures with nicotinamide riboside, a precursor to nicotinamide adenine dinucleotide [NAD+], which is essential to cellular metabolism and to the production of ATP [adenosine triphosphate, a molecule that stores energy for cell use]," Loureiro said.

Supplementation with nicotinamide riboside (1 μM) began 24 hours before exposure to benzo[a]pyrene and continued daily. Because benzo[a]pyrene is absorbed rapidly and biotransformed, it has to be replenished in the cell cultures every day, Loureiro explained.

At the end of the seven-day period, the cells were transferred to a semi-solid medium containing agarose, a polysaccharide obtained from algae, in order to prevent adhesion to the culture dish. The researcher says that a normal epithelial cell is unable to grow in this semi-solid medium without anchorage. "To make this possible, the expression of a number of genes and proteins must be altered so as to favor tumor development, for example by silencing the expression of cadherins [calcium-dependent adhesion molecules that form junctions to bind nearby cells together]," said Loureiro.

Analysis performed during the incubation period showed the occurrence of DNA alterations—both genetic (lesions that caused mutations in the nucleotide sequence) and epigenetic (increased levels of 5-methylcytosine, which alters gene expression). Cells grown in the semi-solid medium displayed global hypomethylation (reduction in levels of 5-methylcytosine), a characteristic of tumor cells.

Supplementing cells exposed to the carcinogen with nicotinamide riboside yielded positive results since they proved unable to grow in the agar medium, displaying similar behavior to the control cells, which were not exposed to benzo[a]pyrene.

Explore further: 'Epigenetic' changes from cigarette smoke may be first step in lung cancer development

Related Stories

'Epigenetic' changes from cigarette smoke may be first step in lung cancer development

September 11, 2017
Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called "epigenetic" changes in the cells ...

Preclinical study suggests E-cigarettes may promote lung cancer in high-risk individuals

January 9, 2014
Exposing human lung cells with genetic mutations associated with high risk for lung cancer to the chemicals in electronic-cigarette (e-cigarette) vapor enhanced the cells' cancerous behaviors, according to preliminary results ...

Altered primary chromatin structures and their implications in cancer development

April 26, 2016
Cancer development is a complex process involving both genetic and epigenetic changes. Genetic changes in oncogenes and tumor-suppressor genes are generally considered as primary causes, since these genes may directly regulate ...

Recommended for you

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

An integrated approach to finding new treatments for breast cancer

December 12, 2018
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.